Endotronix
Endotronix, Inc. is a Naperville, Illinois medical device and digital health company founded in 2007 and acquired by Edwards Lifesciences in July 2024, where it now operates as a wholly owned subsidiary. Endotronix builds the Cordella Heart Failure System, an integrated remote heart-failure management platform combining an implantable wireless pulmonary artery (PA) pressure sensor — granted FDA premarket approval in June 2024 — with a patient-facing myCordella tablet application, connected home vitals peripherals (blood pressure cuff, weight scale, pulse oximeter), and the myCordella Patient Management Portal, a cloud-based web application clinicians use to review transmitted PA pressure, vitals and symptom data and to titrate guideline-directed medical therapy. The company publishes clinical evidence (PROACTIVE-HF), instructions for use and device manuals, but operates no public developer program: there is no developer portal, API reference, SDK, webhook catalog or machine-readable specification on any Endotronix host.
Endotronix is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Digital Health, Remote Patient Monitoring, and Cardiology.
Endotronix’s developer surface includes support, engineering blog, and 12 more developer resources.
Kin Score
Pricing Plans 1
Published pricing tiers and plan structures.
Rate Limits 1
Documented rate limits and quota policies.
Endotronix Rate Limits
RATE LIMITSSecurity Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 3
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Other 2
Properties that don't map to a standard resource type